An international multidisciplinary research team led by the School of Life Sciences at CUHK has uncovered a novel molecular mechanism driving the neuropathological features of myotonic dystrophy type 1 (DM1).

An interdisciplinary team from CU Medicine developed new synbiotics SCM06 to address anxiety-related symptoms in children. The synbiotics was proven in a clinical study which can alleviate anxiety and sensory sensitivity symptoms in children with ASD.

A multi-centre research team led by Hunan Cancer Hospital and supported CU Medicine has discovered that immunochemotherapy administered before 3 p.m. significantly enhances efficacy in advanced lung cancer patients.

A research team from the Department of Electronic Engineering at CUHK has developed chip-scale “digital fingerprint” technology based on carbon nanotubes, offering high-level security for smart devices, particularly against attacks targeting artificial intelligence (AI) and machine learning systems.

A research team led by Professor Lu Yi-chun, Professor in the Department of Mechanical and Automation Engineering at CUHK, has successfully developed a new high-energy-density nickel-manganese-cobalt lithium-ion battery using an innovative electrolyte.

A study conducted by CU Medicine has revealed that the recurrence rate of MPE drops to 12% in patients with malignancy after undergoing percutaneous balloon pericardiotomy (PBP) —an 80% reduction compared to PC.

CUHK’s gravitational-wave group is driving international efforts to achieve the first detection of a lensed multi-messenger event.

A joint CUHK-Youth Diabetes Action programme has provided over 900 young diabetics with continuous glucose monitors, significantly improving glucose control and reducing risks of severe hypoglycaemia and ketoacidosis.

CUHK researchers unlock the pathway for piecemeal removal of plant mitochondria to cope with heat stress, shedding light on how plants adapt to rising global temperatures.

Researchers from CUHK and Oxford University have developed a predictive model to estimate the lifetime risks of stroke, cancer and premature death in diabetic patients, enabling doctors to provide more personalised treatment.

A CUHK-led multinational study introduces a new way to explore the Sun's hidden magnetic fields using teraelectronvolt (TeV) gamma rays.

Rooted in two decades of research, CUHK Professor Edwin Chan Ho-yin founded the biotech start-up Rare Power to develop treatments for rare neurodegenerative diseases, earning a finalist spot in this year’s Spirit of Hong Kong Awards.